Your browser doesn't support javascript.
loading
A Phase I Dose-Escalation Study of Linsitinib (OSI-906), a Small-Molecule Dual Insulin-Like Growth Factor-1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer.
Davis, S Lindsey; Eckhardt, S Gail; Diamond, Jennifer R; Messersmith, Wells A; Dasari, Arvind; Weekes, Colin D; Lieu, Christopher H; Kane, Madeline; Choon Tan, Aik; Pitts, Todd M; Leong, Stephen.
Afiliación
  • Davis SL; University of Colorado Cancer Center, Aurora, Colorado, USA sarah.davis@ucdenver.edu.
  • Eckhardt SG; The University of Texas at Austin Dell Medical School, Austin, Texas, USA.
  • Diamond JR; University of Colorado Cancer Center, Aurora, Colorado, USA.
  • Messersmith WA; University of Colorado Cancer Center, Aurora, Colorado, USA.
  • Dasari A; MD Anderson Cancer Center, Houston, Texas, USA.
  • Weekes CD; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Lieu CH; University of Colorado Cancer Center, Aurora, Colorado, USA.
  • Kane M; University of Colorado Cancer Center, Aurora, Colorado, USA.
  • Choon Tan A; University of Colorado Cancer Center, Aurora, Colorado, USA.
  • Pitts TM; University of Colorado Cancer Center, Aurora, Colorado, USA.
  • Leong S; University of Colorado Cancer Center, Aurora, Colorado, USA.
Oncologist ; 23(12): 1409-e140, 2018 12.
Article en En | MEDLINE | ID: mdl-30139840
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazinas / Factor I del Crecimiento Similar a la Insulina / Irinotecán / Imidazoles Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazinas / Factor I del Crecimiento Similar a la Insulina / Irinotecán / Imidazoles Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos